Parkinsonian symptoms
Pro Research Analysisby 
Searched over 200M research papers for "parkinsonian symptoms"
Parkinsonian Symptoms: Clinical Features and Pathophysiology
Cardinal Motor Symptoms in Parkinson's Disease
Parkinson's disease (PD) is primarily characterized by a set of cardinal motor symptoms, which include rest tremor, bradykinesia (slowness of movement), rigidity, and postural instability1 2 4 8. These symptoms are the result of dopamine depletion in the striatum, a critical area of the brain involved in movement regulation2 4. The tremor typically begins on one side of the body, often in one hand, and can extend to the arms, legs, feet, and face8. Rigidity refers to the stiffness of the limbs and torso, while bradykinesia and akinesia denote slow movement and an inability to move, respectively8.
Secondary Motor Symptoms
In addition to the primary motor symptoms, PD patients often exhibit secondary motor symptoms such as hypomimia (reduced facial expression), dysarthria (speech difficulties), dysphagia (swallowing difficulties), sialorrhoea (excessive salivation), micrographia (small handwriting), shuffling gait, festination (rapid, short steps), freezing, dystonia (muscle contractions), and glabellar reflexes (persistent blinking)1 6. These symptoms further complicate the motor deficits experienced by PD patients and can significantly impact their quality of life.
Non-Motor Symptoms
Non-motor symptoms are increasingly recognized as major determinants of quality of life in PD patients. These include autonomic dysfunction (e.g., hypotension, constipation, diaphoresis), cognitive and neurobehavioral abnormalities (e.g., dementia, depression, anxiety, apathy, fatigue), sleep disorders, and sensory abnormalities such as anosmia (loss of smell), paresthesias (tingling sensations), and pain1 3 4 9. These symptoms often precede the motor symptoms and can serve as early indicators of the disease10.
Pathophysiological Mechanisms
The pathophysiology of PD involves complex interactions between genetic, environmental, and immunologic factors. The hallmark of PD is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to dopamine deficiency in the basal ganglia2 4 9. This deficiency disrupts the normal functioning of the basal ganglia-thalamo-cortical loops, resulting in the characteristic motor symptoms of PD2 6. Abnormal synchronous oscillating neuronal activity within these loops is believed to be a key factor in the generation of parkinsonian symptoms2.
Genetic and Environmental Factors
Recent genetic discoveries have identified mutations in several genes, such as α-synuclein, LRRK2, and tau, which are associated with PD and related disorders10. These genetic factors, along with environmental toxins, contribute to the degeneration of dopaminergic circuits in the basal ganglia10. The presence of Lewy bodies, which are brain deposits containing α-synuclein, is a pathological hallmark of PD9.
Treatment and Management
Current treatments for PD primarily focus on alleviating symptoms rather than modifying the disease course. Dopamine replacement therapy, such as levodopa, remains the mainstay treatment for motor symptoms4 9. Neurosurgical procedures, including deep brain stimulation (DBS), can also help ameliorate motor symptoms by resetting abnormal brain activity2 4. However, as the disease progresses, motor symptoms often become intractable to therapy, and non-motor symptoms become more prominent4 9.
Conclusion
Parkinson's disease is a complex neurological disorder characterized by a wide range of motor and non-motor symptoms. Understanding the clinical features and pathophysiological mechanisms of PD is crucial for accurate diagnosis and effective management. While current treatments focus on symptom relief, ongoing research aims to develop disease-modifying therapies that can slow or halt the progression of this debilitating condition.
Sources and full results
Most relevant research papers on this topic
Parkinson’s disease: clinical features and diagnosis
Understanding the broad spectrum of clinical manifestations of Parkinson's disease is essential for proper diagnosis, with genetic mutations, neuroimaging abnormalities, and other tests potentially improving diagnosis and risk identification.
Systematic Review
Highly CitedPathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back
Parkinson's symptoms are likely due to abnormal synchronous neuronal activity within the basal ganglia, with cerebello-thalamic mechanisms and neurotransmitter systems playing a minor role in generating and maintaining symptoms.
Highly CitedNonmotor Symptoms in Parkinson's Disease
Nonmotor symptoms in Parkinson's disease significantly impact quality of life, with behavioral and somatic symptoms being key determinants.
Highly CitedDescription of Parkinson's Disease as a Clinical Syndrome
Parkinson's disease is a slowly progressive parkinsonian syndrome characterized by motor symptoms and nonmotor symptoms, with no proven means to slow its progression.
Highly CitedFunctional Motor Symptoms in Parkinson's Disease and Functional Parkinsonism: A Systematic Review.
Functional symptoms in Parkinson's disease and functional parkinsonism may have a possible relationship, and clinicians should consider the possibility of functional symptoms in PD patients.
Systematic ReviewMotor symptoms in Parkinson’s disease: A unified framework
Parkinson's disease motor symptoms reflect dysfunction in neural structures responsible for action selection, motor sequencing, and coordination and execution of movement.
Highly CitedInitial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
Early Parkinson's disease symptoms involve motor, cognitive, and psychiatric impairments, with distinct mechanisms explaining the wide range of symptoms at diagnosis.
Highly CitedParkinson Disease
Parkinson's disease often begins with tremors in limbs, followed by stiffness, slow movement, and impaired balance, which worsen over time.
Highly CitedParkinson's disease: Autoimmunity and neuroinflammation.
Autoimmune and neuroinflammation play significant roles in Parkinson's disease pathogenesis, and immunomodulatory therapeutic strategies may offer potential treatments for neurodegeneration.
Highly CitedGenetics of Parkinson’s disease and related disorders
Recent genetic discoveries suggest that Parkinson's disease and related disorders are part of a continuous disease spectrum, with mutations in -synuclein, LRRK2, tau, and environmental toxins playing key roles in degeneration of dopaminergic circuits.
Rigorous Journal